|
$1.5B buyout for failed P3 drug company
|
11
|
Resverlogix Corp.
|
Nov 30, 2020 01:50PM
|
|
ABL competitors
|
5
|
Resverlogix Corp.
|
Jun 16, 2021 03:21PM
|
|
Anti-inflammatory for covid
|
5
|
Resverlogix Corp.
|
Sep 14, 2020 05:34PM
|
|
Antiviral
|
6
|
Resverlogix Corp.
|
Apr 29, 2021 03:48PM
|
|
Bristol Myers buys Myokardia for $13B
|
8
|
Resverlogix Corp.
|
Oct 05, 2020 03:31PM
|
|
Carotid stenosis study
|
2
|
Resverlogix Corp.
|
Feb 26, 2020 05:01PM
|
|
Congestive Heart Failure
|
7
|
Resverlogix Corp.
|
Nov 18, 2019 04:30PM
|
|
Dal-Covid trial
|
4
|
Resverlogix Corp.
|
Jul 03, 2021 06:13PM
|
|
Diabetes, dementia, and ABL
|
5
|
Resverlogix Corp.
|
Dec 21, 2019 04:57AM
|
|
Don's latest presentation
|
4
|
Resverlogix Corp.
|
Sep 22, 2020 06:40AM
|
|
Don’s education
|
7
|
Resverlogix Corp.
|
Jul 14, 2020 08:02PM
|
|
Epigenetics, CHF, and ABL
|
8
|
Resverlogix Corp.
|
Dec 20, 2019 03:13PM
|
|
Fiercemarkets article
|
5
|
Resverlogix Corp.
|
Mar 23, 2021 11:10AM
|
|
FiercePharma article
|
3
|
Resverlogix Corp.
|
Jul 23, 2020 05:52PM
|
|
Heart failure study
|
21
|
Resverlogix Corp.
|
Feb 07, 2021 10:32AM
|
|
Hepalink, heparin, and covid
|
3
|
Resverlogix Corp.
|
Aug 06, 2020 05:49PM
|
|
HIV
|
7
|
Resverlogix Corp.
|
Nov 18, 2019 04:51PM
|
|
HIV
|
3
|
Resverlogix Corp.
|
Jan 24, 2020 03:35PM
|
|
Insider dealing August
|
1
|
Resverlogix Corp.
|
Sep 01, 2019 10:28AM
|
|
Long covid trials
|
9
|
Resverlogix Corp.
|
Jul 31, 2023 07:03PM
|
